bicalutamide has been researched along with 2-(2-phenoxyethylsulfonyl)-1H-benzimidazole in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Axerio-Cilies, P; Ban, F; Cherkasov, A; Frewin, K; Hassona, MD; Labriere, C; Lack, NA; Leblanc, E; Li, H; Munuganti, RS; Rennie, PS; Singh, K; Tomlinson Guns, E; Young, R | 1 |
1 other study(ies) available for bicalutamide and 2-(2-phenoxyethylsulfonyl)-1H-benzimidazole
Article | Year |
---|---|
Targeting the binding function 3 (BF3) site of the androgen receptor through virtual screening. 2. development of 2-((2-phenoxyethyl) thio)-1H-benzimidazole derivatives.
Topics: Benzimidazoles; Binding Sites; Cell Line, Tumor; Crystallography, X-Ray; Humans; Male; Molecular Structure; Prostate-Specific Antigen; Receptors, Androgen | 2013 |